FDA simplifies rules governing use of popular acne medication isotretinoin
The iPLEDGE program is a risk management system mandated by the U.S. Food and Drug Administration to prevent fetal exposure to isotretinoin, a medication used for severe acne that doesn’t … Click to Continue »
View original article
Contributor:
